type here...

CATEGORIES

Autoimmune Conditions

LATEST

12345Page 3 of 5

TRENDING

EDITORS CHOICE

How COVID and the Power of Now Killed Scientific Peer Review

Gil Bashe, Medika Life Editor -
How long do or should clinical trials take – well, it depends – but often years. Science takes time. It demands rigor and objectivity. It’s not a “now” pursuit.

CAR T Therapy: From Cancer To Autoimmune Disease, The Lupus Example

William Haseltine, PhD -
Here we draw attention to promising findings for CAR T lupus treatment. The foundations of CAR T, as well as applications for B cell cancers and multiple myeloma, can be found in earlier works in the series.

Artificial Intelligence, Microbiome, and Predicting Liver Disease

Michael Hunter, MD -
Increasing evidence suggests an interplay between the gut microbiome and nonalcoholic fatty liver disease (NAFLD). The role of the microbiome in the early detection of the condition remains unclear.

Long COVID-19: What Doctors Want You to Know

Michael Hunter, MD -
Approximately 15 percent of those with a COVID-19 infection will develop long COVID. Long COVID is prevalent and more common among females and older individuals.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories